BioCentury
ARTICLE | Financial News

RIP Mark Schoenebaum, treasured biopharma analyst

August 26, 2019 4:38 AM UTC

Mark Schoenebaum, an admired biopharma equity analyst, died over the weekend.

Schoenebaum resigned as senior managing director and head of healthcare/biotech & pharma equity analyst at Evercore ISI in 2017. Prior to joining Evercore in 2010, he worked for a decade as a biotech analyst at Deutsche Bank, Bear Stearns & Co., Piper Jaffray and CIBC. Institutional Investor named him as the top-ranked biotech analyst every year from 2004 to 2017...